| Thomas Mukai, MD | |
|
10400 75th St, Kenosha, WI 53142-7884 | |
| (262) 948-5600 | |
| Not Available |
| Full Name | Thomas Mukai |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 10400 75th St, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457842932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 75615 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
| Aurora Lakeland Medical Center | Elkhorn, WI | Hospital |
| Aurora Memorial Hospital Burlington | Burlington, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Experts in the use of comprehensive geriatric assessment for hospitalized elders and immunizations in older adults, and the author of the 2012 Beers Criteria - a guide to medication use in elders - will be featured at the 14th Annual University of Louisville Geriatrics Healthcare Symposium.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Sharing a mutual goal of helping researchers turn their discoveries into products that help people and stimulate the economy, IP Advocate (http://www.IPAdvocate.org) founder and noted scientist Dr. Renee Kaswan is collaborating with the Ewing Marion Kauffman Foundation (http://www.kauffman.org) on a range of education and policy initiatives.
A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries "free-flowing" in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of America).
› Verified 5 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Experts in the use of comprehensive geriatric assessment for hospitalized elders and immunizations in older adults, and the author of the 2012 Beers Criteria - a guide to medication use in elders - will be featured at the 14th Annual University of Louisville Geriatrics Healthcare Symposium.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Sharing a mutual goal of helping researchers turn their discoveries into products that help people and stimulate the economy, IP Advocate (http://www.IPAdvocate.org) founder and noted scientist Dr. Renee Kaswan is collaborating with the Ewing Marion Kauffman Foundation (http://www.kauffman.org) on a range of education and policy initiatives.
A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries "free-flowing" in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of America).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Mukai, MD 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (262) 945-5600 | Thomas Mukai, MD 10400 75th St, Kenosha, WI 53142-7884 Ph: (262) 948-5600 |
News Archive
Experts in the use of comprehensive geriatric assessment for hospitalized elders and immunizations in older adults, and the author of the 2012 Beers Criteria - a guide to medication use in elders - will be featured at the 14th Annual University of Louisville Geriatrics Healthcare Symposium.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Sharing a mutual goal of helping researchers turn their discoveries into products that help people and stimulate the economy, IP Advocate (http://www.IPAdvocate.org) founder and noted scientist Dr. Renee Kaswan is collaborating with the Ewing Marion Kauffman Foundation (http://www.kauffman.org) on a range of education and policy initiatives.
A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries "free-flowing" in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of America).
› Verified 5 days ago
David Eric Farkas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Aurora Medical Center, Kenosha, WI 53142 Phone: 262-697-7000 Fax: 630-734-1560 | |
Ms. Kimberly Roberson, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Terry Zehr, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-7000 | |
Manuel A. Rivera, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 4536 22nd Ave, Kenosha, WI 53140 Phone: 262-656-0044 Fax: 262-653-2218 | |
Mounica D Robinson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Benjamin A Feinzimer, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Kenosha, WI 53143 Phone: 414-290-6720 Fax: 414-290-6755 | |
Therese Marie Whitt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Aurora Medical Center, Kenosha, WI 53142 Phone: 262-697-7000 Fax: 630-734-1560 |